The Link Between Autism, Hormones, and PMDD – What You Need to Know

Introduction

Hormonal fluctuations significantly influence mood, energy levels, and overall well-being. For autistic individuals, these changes can be particularly impactful, affecting sensory sensitivities and emotional regulation. One area of growing interest is the connection between autism and premenstrual dysphoric disorder (PMDD)—a severe form of premenstrual syndrome characterised by intense mood disturbances, anxiety, and physical discomfort.

While research on the intersection of autism and PMDD is still developing, emerging evidence suggests that autistic individuals may experience more severe premenstrual symptoms compared to their non-autistic counterparts. This blog delves into the scientific findings on this topic and offers insights into managing PMDD symptoms for those on the autism spectrum.

Understanding Autism and Hormonal Sensitivity

Autistic individuals often report heightened sensory perceptions and emotional intensities, which may be linked to differences in how their brains process hormones. Key hormones such as estrogen, progesterone, and testosterone interact with neurotransmitters like dopamine and serotonin, both of which function differently in autistic brains.

• Estrogen and Progesterone: These hormones fluctuate throughout the menstrual cycle, influencing mood and cognition. Estrogen is known to enhance dopamine activity, aiding in focus and mood regulation, while the withdrawal of progesterone before menstruation can lead to irritability and depression.

• Testosterone: Prenatal exposure to testosterone has been associated with the development of autistic traits, though its role in adulthood remains less clear. Some autistic individuals report significant mood shifts corresponding with changes in testosterone levels, particularly during puberty and perimenopause.

These hormonal sensitivities suggest that autistic individuals may experience more pronounced emotional and physical symptoms during hormonal fluctuations, especially in the luteal phase of the menstrual cycle when PMDD symptoms typically manifest.

What is PMDD?

PMDD is a severe, debilitating condition affecting approximately 5-8% of menstruating individuals. Unlike typical premenstrual syndrome (PMS), which causes mild discomfort and mood changes, PMDD is characterised by:

• Severe mood swings, including feelings of rage, hopelessness, and paranoia

• Depression and suicidal ideation

• Extreme fatigue and cognitive difficulties

• Heightened sensory sensitivities

• Physical symptoms such as headaches, bloating, and joint pain

PMDD arises from an abnormal response to normal hormonal fluctuations, particularly the rapid decline in progesterone that occurs before menstruation. Given that autistic individuals often experience heightened sensitivity to hormonal changes, they may be more susceptible to PMDD.

The Link Between Autism and PMDD

While research is ongoing, some studies have explored the prevalence of PMDD among autistic individuals:

• Obaydi and Puri (2008) conducted a study comparing women with autism and learning disabilities to a control group with learning disabilities but without autism. They found that 92% of the autistic group met the criteria for PMDD, compared to 11% in the control group. This significant difference suggests a potential link between autism and increased PMDD prevalence.

• Lever and Geurts (2016) reported that nearly 21% of autistic women experienced PMDD, compared to 3% of non-autistic women. This study further supports the notion that autistic individuals may be more prone to severe premenstrual symptoms.

However, it’s important to note that not all studies have found a significant difference. For instance, a study by Groenman et al. (2021) reported that 14.3% of autistic women and 9.5% of non-autistic women met the criteria for PMDD, a difference that was not statistically significant. These varying findings highlight the need for further research to understand the relationship between autism and PMDD fully.

Why Might PMDD Affect Autistic Individuals More Severely?

1. Sensory Sensitivities: Autistic individuals often have heightened sensory processing, making physical symptoms like cramps, headaches, and bloating more distressing.

2. Emotional Regulation Challenges: Difficulties in identifying and expressing emotions, a trait common in autism, can make mood swings and emotional dysregulation associated with PMDD more overwhelming.

3. Progesterone Withdrawal: Sensitivity to hormonal fluctuations, particularly the drop in progesterone before menstruation, may lead to more extreme mood shifts and irritability in autistic individuals.

4. Co-occurring Conditions: Higher rates of anxiety, depression, and ADHD among autistic individuals can intensify PMDD symptoms.

Why This Connection Matters

Despite the significant impact of PMDD on mental health, it is often overlooked or dismissed by healthcare providers, especially in autistic individuals. The overlap between autism traits and PMDD symptoms can make it challenging for professionals to distinguish between chronic autistic traits and cyclical hormonal distress.

Untreated PMDD can lead to:

• Severe mental health crises, including suicidal thoughts

• Increased difficulties in daily functioning

• Misdiagnoses and inappropriate treatments leading to ineffective care

Therefore, awareness and understanding of the autism-PMDD connection are crucial for proper diagnosis and personalised management strategies.

Coping Strategies and Management

Managing PMDD can be challenging, but several strategies may help alleviate symptoms:

Medical Interventions

• Antidepressants: Selective serotonin reuptake inhibitors (SSRIs) have been shown to improve mood symptoms associated with PMDD.

• Hormonal Therapies: Hormonal contraceptives can help regulate estrogen and progesterone levels, though responses vary among individuals.

• Supplements: Nutritional supplements like magnesium, vitamin B6, and calcium may help regulate mood and reduce PMS-related symptoms.

Lifestyle Modifications

• Symptom Tracking: Using apps or journals to monitor symptoms can help identify patterns and predict challenging days.

• Diet and Exercise: Maintaining a balanced diet and regular physical activity can aid in hormone regulation and symptom management.

• Sensory-Friendly Self-Care: Incorporating tools like noise-cancelling headphones, weighted blankets, or aromatherapy can help manage sensory overstimulation.

Self-Advocacy Tips

• Prepare for Medical Appointments: Bringing a detailed symptom diary can help healthcare providers understand your experiences.

• Seek Knowledgeable Providers: Look for healthcare professionals who are experienced in working with autistic individuals and are knowledgeable about PMDD.

• Connect with Support Networks: Engaging with support groups can provide shared experiences and coping strategies.

The Need for More Research and Awareness

The intersection of autism and PMDD is under-researched. Most studies on PMDD have focused on neurotypical populations, often overlooking the unique experiences of autistic individuals.

Advocacy for more inclusive research and neurodivergent-friendly healthcare approaches is essential to improve recognition and treatment of PMDD in autistic individuals.

Conclusion

Hormonal fluctuations can significantly impact autistic individuals, yet the connection between autism and PMDD is often overlooked. With increased awareness, proper diagnosis, and personalised management strategies, autistic individuals can better navigate their hormonal health.

If you suspect you have PMDD, know that you are not alone. Seek medical advice, track your symptoms, and connect with others who understand.

References

Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K., & Hackett, G. (2009). Fetal testosterone and autistic traits. British Journal of Psychology, 100(1), 1-22. https://doi.org/10.1348/000712608X311731

Baron-Cohen, S., Knickmeyer, R. C., & Belmonte, M. K. (2015). Sex differences in the brain: Implications for explaining autism. Science, 310(5749), 819-823. https://doi.org/10.1126/science.1115455

Crane, L., Davies, J., Bremner, L., Pellicano, E., & Allison, C. (2021). Meeting the needs of autistic women. Autism, 25(2), 258-260. https://doi.org/10.1177/1362361320975782

Curley, J. P., Jensen, C. L., Franks, B., & Champagne, F. A. (2021). Programming of neuroendocrine function by early life experience: Mechanisms and implications for adaptation. Frontiers in Neuroendocrinology, 60, 100877. https://doi.org/10.1016/j.yfrne.2020.100877

Eisenlohr-Moul, T. A., Girdler, S. S., Schmalenberger, K. M., Dawson, D. N., & Rubinow, D. R. (2017). Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: The critical role of diary screening. Journal of Psychiatric Research, 86, 22-30. https://doi.org/10.1016/j.jpsychires.2016.11.012

Giltay, E. J., & Enter, D. (2021). The role of estrogen in mood disorders. Journal of Affective Disorders, 290, 90-97. https://doi.org/10.1016/j.jad.2021.04.084

Halbreich, U. (2003). The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology, 28(3), 55-99. https://doi.org/10.1016/S0306-4530(03)00097-0

Hergüner, S., & Mukaddes, N. M. (2009). Premenstrual exacerbation of symptoms in prepubertal and adolescent females with autism. World Journal of Biological Psychiatry, 10(4-2), 816-823. https://doi.org/10.1080/15622970701685213

Kinnaird, E., Stewart, C., & Tchanturia, K. (2019). Investigating alexithymia in autism: A systematic review and meta-analysis. European Psychiatry, 55, 80-89. https://doi.org/10.1016/j.eurpsy.2018.09.004

Lever, A. G., & Geurts, H. M. (2016). Psychiatric co-occurring symptoms and disorders in young, middle-aged, and older adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 46(6), 1916-1930. https://doi.org/10.1007/s10803-016-2722-8

Moseley, R. L., Druen, D., Park, C., Schultz, B., & Pulvermüller, F. (2022). Hormonal cycles and sensory reactivity in autism: Implications for understanding gender differences and autistic burnout. Autism Research, 15(3), 452-467. https://doi.org/10.1002/aur.2651

Murray, C., Rodgers, J., & Zander, E. (2022). Health disparities for autistic individuals: A review of research and future directions. The Lancet Psychiatry, 9(5), 370-382. https://doi.org/10.1016/S2215-0366(22)00066-2

Obaydi, T., & Puri, B. K. (2008). Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in women with autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(8), 1873-1876. https://doi.org/10.1016/j.pnpbp.2008.08.015

Schmidt, P. J., Martinez, P. E., Nieman, L. K., Koziol, D. E., Thompson, K. D., & Rubinow, D. R. (2017). Premenstrual dysphoria and the serotonin system: Sex steroids, neurosteroids, and neuropeptides. Journal of Clinical Endocrinology & Metabolism, 102(1), 167-175. https://doi.org/10.1210/jc.2016-2585

Schneider, D. W., Tierney, S., & Kilbey, E. (2019). Premenstrual dysphoric disorder: Misdiagnoses and misunderstandings. Women’s Mental Health Review, 26(4), 201-210. https://doi.org/10.1016/j.wmhr.2019.04.003

Yonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008). Premenstrual syndrome. The Lancet, 371(9619), 1200-1210. https://doi.org/10.1016/S0140-6736(08)60527-9